Merck & Company, Inc.
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD
Company details
YOUFIREYOUFIREA Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD
Company detailsA Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers (MK-5909-005)
Company detailsA Study of SPY002-091 in Healthy Volunteers
Company detailsStudy Evaluating AZD7798 for Treatment in Crohn's Disease Patients With an Ileostomy
Company detailsProspective Observational Multicenter Study of Patients With AH and CKD Markers in Kazakhstan (PROGRESS-CKD)
Company detailsAxitinib + Ipilimumab in Advanced Melanoma
Company detailsAvelumab Program Rollover Study
Company detailsSubstudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A)
Company detailsSubstudy 03B: A Study of Immune and Targeted Combination Therapies in Participants With Second Line Plus (2L+) Renal Cell Carcinoma (MK-3475-03B/KEYMAKER-U03)
Company detailsA Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy
Company detailsA Study to Learn How Different Amounts of the Study Medicine Called PF-07999415 Are Tolerated and Act in the Body in Healthy Adults
Company detailsA Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors
Company detailsA Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease
Company detailsA Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC
Company detailsA Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants
Company detailsSelumetinib and Olaparib in Solid Tumors
Company detailsStudy to Investigate the Safety, Tolerability, and Pharmacokinetics of GB-7624 in Healthy Adult Participants
Company detailsONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer
Company detailsMagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Company detailsA Study to Learn About Study Medicine Lorlatinib, as a First-line Treatment in Chinese Adults With ALK-positive a/mNSCLC
Company detailsAcalabrutinib and Durvalumab in Primary and Secondary Central Nervous System Lymphoma
Company detailsTrastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)
Company detailsA Real-World Assessment of the Demographic, Clinical Characteristics and Outcomes of a Brazilian Cohort of Previously Untreated Extensive Stage-Small Cell Lung Cancer Receiving Durvalumab Combined With Platinum-Etoposide in (ES-SCLC) in Brazil
Company detailsBoosting Regional Integration for COP D Care Through Guided Implementation and Audit of Post Exacerbation Transition Bundle
Company detailsEffect of Mavacamten Treatment on Coronary Flow Reserve in oHCM
Company detailsA Phase 1 Study of Navlimetostat Tablet Formulations
Company detailsA Two-armed Real-world Study of Ozempic (OW Semaglutide) to Evaluate Its Adherence and Persistence Compared With Other Anti-diabetic Drugs Among Adult T2DM Patients in China
Company detailsA Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High Risk of Severe RSV Disease.
Company detailsA Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults
Company detailsA Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors
Company detailsHypofractionated Whole-Pelvis Radiotherapy (WPRT) vs Conventionally-Fractionated WPRT in Prostate Cancer
Company detailsA Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Company detailsA Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male Participants
Company detailsA Retrospective Study to Evaluate Treat-to-Target and Disease Modification in Adult Participants With Crohn's Disease and Ulcerative Colitis in Real World Setting
Company detailsA Study to Assess the Adverse Events and How Bretisilocin Intramuscular Injection Moves Through the Body of Healthy Adult Participants
Company detailsA Study to Evaluate How Multiple Doses of Itraconazole Interacts With Nacresertib in Healthy Adult Participants
Company detailsStudy to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Company detailsRadiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer
Company detailsStudy Evaluating the Safety and Efficacy of MEDI5752 in Combination With Stereotactic Radiotherapy in Patients With Metastatic Sarcoma
Company detailsImpact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathlessness
Company detailsExplore the Efficacy and Mechanism of Action of Tezepelumab in Eosinophilic Granulomatosis With Polyangiitis
Company detailsMaintenance Durvalumab (MEDI4736) and Olaparib (AZD2281) After Standard 1st Line Treatment (Carboplatin/Cisplatin, Etoposide, Durvalumab) in HRD Positive Extensive Disease (ED) Small-cell Lung Cancer (SCLC)
Company detailsDetermining Efficacy of an Artificial Intelligence-based System for Heart Failure Detection Through Interpretation of Electrocardiograms (DECISION)
Company detailsCharacterizing the Human Airway Immune Response to FluMist Vaccination
Company detailsCombining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancer
Company detailsNivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma
Company detailsStudy of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment
Company detailsBelatacept in De Novo Heart Transplantation
Company detailsNeoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma
Company detailsFilgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Company detailsStudy of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection
Company detailsClinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients
Company detailsA Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
Company detailsA Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)
Company detailsA Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)
Company detailsA Study to Compare Two Different Sleep Tests in Participants With No Symptoms or Early Symptoms of Alzheimer's Disease
Company detailsA Study of Food Effect on Tersolisib (LY4064809) in Healthy Participants
Company detailsPYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer
Company detailsTest-retest Study With [18F]FBB in Cardiac Amyloidosis
Company detailsCombination Study of Guadecitabine/ASTX727 and Pembrolizumab
Company detailsStudy of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)
Company detailsPhase II Trial of Trilaciclib, Pembrolizumab, Gemcitabine and Carboplatin in Metastatic Triple-Negative Breast Cancer
Company detailsDon't be Late! Postponing Cognitive Decline and Preventing Early Unemployment in People With Multiple Sclerosis
Company detailsCharacterization, Health Resource Utilization and Biomarkers in Early-stage
Company detailsThe Intelligent Diabetes TelemonitoRing Using Decision Support to Treat Patients on Insulin Therapy
Company detailsRole of Immune System in Obesity-related Inflammation and Cardiometabolic Risk
Company detailsRimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US
Company detailsMAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Company detailsHIV Prevention With PrEP Among People on Opioid Replacement Therapy
Company detailsA Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG
Company detailsDe-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Transplant Recipients
Company detailsA Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Company detailsTACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)
Company detailsPhase 2 DoceRamPem for Patients With Metastatic or Recurrent NSCLC Who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade
Company detailsA Clinical Study of MK-4082 in Healthy Overweight Participants (MK-4082-002)
Company detailsA Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension
Company detailsA Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Company detailsA Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)
Company detailsA Study of MK-7240 in Healthy Participants (MK-7240-009)
Company detailsA Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body Weight
Company detailsA Study to Learn How Different Forms of the Study Medicine Called PF-08049820 Are Absorbed and Eliminated in Healthy Adults
Company detailsA Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors
Company detailsA Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)
Company detailsA Clinical Study of MK-7262 and Enlicitide in Healthy Participants (MK-7262-003)
Company detailsA Phase I, Cross-over Study Comparing the Relative Bioavailability of Laroprovstat Plus Ezetimibe Fixed Combination Drug Products Versus Their Single Therapy Products in Healthy Adults
Company detailsA Study to Learn About How Food Affects the Uptake of Study Medicine Prifetrastat Into the Blood in Healthy Adults
Company detailsA Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 Diabetes
Company detailsA Study to Learn How the Study Medicine Called Etrasimod is Taken up Into Blood and Breastmilk of Healthy Breastfeeding Women
Company detailsA Study of Nemtabrutinib in Participants With Moderate Hepatic Impairment (MK-1026-015)
Company detailsStudy of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)
Company detailsA Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes
Company detailsA Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234
Company detailsA Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)
Company detailsA Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India.
Company detailsA Study of Belzutifan (MK-6482) in Combination With Palbociclib Versus Belzutifan Monotherapy in Participants With Advanced Renal Cell Carcinoma (MK-6482-024/LITESPARK-024)
Company detailsA Clinical Trial of MK-1403 in Healthy Participants (MK-1403-007)
Company detailsKorean Post-marketing Surveillance for Xeljanz XR
Company detailsAcalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas
Company detailsA Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants.
Company detailsPembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer
Company detailsStudy to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Company detailsKorean Post-marketing Surveillance Ngenla® Pre-filled Pen Injection for the Treatment of Pediatric Patients With Growth Disturbance Due to Insufficient Secretion of Growth Hormone
Company detailsCan Stories Encourage the Elderly to Vaccinate? Combining Viewer-tailored Personal Narrative Videos With Informational Videos to Improve Vaccine Uptake Among Older Adults
Company detailsA Study to Investigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastatic Gastric or GEJ Adenocarcinoma Expressing CLDN18.2
Company detailsA Clinical Trial of MK-4082 in Healthy Participants (MK-4082-005)
Company detailsA Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Company detailsThe Burden of Atypical Hemolytic Uremic Syndrome and The Clinical Characteristics of Patients in Egyptian Hospitals A Multicenter, Observational, Retrospective Cohort Study in Egypt
Company detailsHER2-positive Metastatic Breast Cancer in Kazakhstan
Company detailsA Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
Company detailsEffect of Hepatic Impairment on the Pharmacokinetics of Mirdametinib
Company detailsCharacteristics and Treatment Experiences of Individuals Using Injectable Semaglutide for Weight Management, a Cross-sectional Time-series Analysis, Multi-country Study.
Company detailsKorean Real-world Study on MASLD/MASH Outcomes.
Company detailsA Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
Company detailsSafety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors
Company detailsA Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE)
Company detailsGenetic Testing in Guiding Treatment for Patients With Brain Metastases
Company detailsA Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA)
Company detailsA Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Company detailsEffect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)
Company detailsA Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function
Company details
